These Pharmas Could Be On The Hook For Billions In The Opioid EpidemicInvestors Business Daily • 07/22/19
Mylan And Teva: History Shows Buying The Current Pain Could Be Your Big Future GainSeeking Alpha • 06/20/19
Mylan (MYL) Down 18.8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/06/19
An Antitrust Lawsuit Could Cost Generic Pharmas Billions Of DollarsInvestors Business Daily • 05/24/19
Mylan's stock falls toward 7 1/2-year low; credit rating now in danger of downgrade to 'junk' at FitchMarket Watch • 05/15/19
Mylan N.V. (MYL) CEO Heather Bresch on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19
Mylan notified that several states intend to file new complaint alleging anticompetitive conductMarket Watch • 05/07/19